Biofrontera Inc expected to post a loss of $1.19 a share - Earnings Preview

Biofrontera

13/03/2024 20:03

* Biofrontera Inc  BFRI.OQ   BFRI.O  is expected to show a
rise in
quarterly revenue when it reports  results on March 15 for the
period ending December 31 2023
    * The Woburn Massachusetts-based  company is expected to
report a
13.6% increase in revenue to $11.522 million from $10.14 million
a year ago, according to the mean estimate from 2 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Biofrontera Inc is for a
loss
of $1.19 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Biofrontera
Inc
is $16.00​, above​ its last closing price of $1.31. ​​​

This summary was machine generated March 13 at 20:03 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)